Hypothalamic-pituitary-adrenal axis function after inhaled corticosteroids: Unreliability of urinary free cortisol estimation

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 10, 2002, Pages 4541-4546

  Fink, Richard S ^a   Pierre, Lisa N ^a   Daley Yates, Peter T ^b   Richards, David H ^b   Gibson, Anthony ^c   Honour, John W ^b  

^a WEST MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; HYDROCORTISONE; TRIAMCINOLONE ACETONIDE;

ADRENAL DISEASE; ADRENAL SUPPRESSION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID METABOLISM; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DIAGNOSTIC VALUE; DISEASE MARKER; DRUG DELIVERY SYSTEM; DRUG SAFETY; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE URINE LEVEL; HYPOPHYSIS FUNCTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOASSAY; MALE; METERED DOSE INHALER; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STEROIDOGENESIS; URINALYSIS;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENAL GLANDS; ADULT; ANDROSTADIENES; BUDESONIDE; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; HUMANS; HYDROCORTISONE; HYPOTHALAMUS; MALE; PITUITARY GLAND; PLACEBOS; SPECIMEN HANDLING; TRIAMCINOLONE ACETONIDE;

EID: 0036774378     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020287     Document Type: Article

References (23)

1. Chrousos GP, Harris AG 1997 Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. I. General principles. Neuroimmunomodulation 5:277-287
2. Honour JW 1994 Hypothalamic-pituitary-adrenal axis. Respir Med 88(Suppl A):9-15
3. Dekhuijzen PNR, Honour JW 2000 Inhaled corticosteroids and the hypothalamic-pituitary-adrenal axis. Eur Respir J 94:627-631
4. Lipworth BJ, Seckl JR 1997 Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroids. Thorax 52:476-482
5. Law CM, Marchant JL, Honour JW, Preece MA, Warner JO 1986 Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate. Lancet 1:943-944
6. Chrousos GP, Harris AG 1997 Hypothalamic-pituitary-adrenal axis suppres sion and inhaled corticosteroid therapy. II. Review of the literature. Neuroimmunomodulation 5:288-308
7. Meijer RJ, Kerstjens HAM, Arends LR, Kauffman HF, Koeter GH, Postma DS 1999 Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax 54:894-899
8. Meijer RJ, Postma DS, Arends LR, Jagt PH Kerstjens HAM 2001 RIA method is not reliable to measure cortisol suppression when using oral prednisolone in asthma. Am J Respir Crit Care Med 163:A585
9. Morineau G, Gosling J, Patricot M-C, Soliman H, Boudou P, Al Halnak A, Le Brun G, Brerault J-L, Julien R, Villette J-M, Fiet J 1997 Convenient chromatographic prepurification step before measurement of urinary, cortisol by radioimmunoassay Clin Chem 43:786-793
10. Murphy BEP 2000 How much UFC is really cortisol? Clin Chem 46:793-794
11. Honour JW 1997 Steroid profiling. Ann Clin Biochem 34:32-44
12. Priftis K, Milner AD, Conway E, Honour JW 1990 Adrenal function in asthma. Arch Dis Child 65:838-840
13. Yiallouros PK, Milner AD, Conway E, Honour JW 1997 Adrenal function and high dose inhaled corticosteroids for asthma. Arch Dis Child 76:405-410
14. Derendorf H 1997 Pharmacokinetic and pharmacodynamic properties of in haled corticosteroids in relation to efficacy and safety., Respir Med 91(Suppl A):22-28
15. Edsbacker S, Jonsson S, Lindberg C, Ryrfeldt A, Thalen A 1983 Metabolic pathways of the topical glucocorticoid budesonide in man. Drug Metab Dispos 11:590-596
16. Honour JW 2000 Fluticasone in asthma. Thorax 55:724
17. Thorsson L, Kallen A 2000 A randomized controlled assessment of the sys temic activity of budesonide when given once or twice daily via Turbuhaler. Eur J Clin Pharmacol 56:207-210
18. Ryrfeldt A, Andersson P, Edabaeker S, Toensson M, Davies D, Pauwels R 1982 Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis. 63:86-95
19. Argenti D, Shah B, Heald D 1999 A pharmacokinetic study to evaluate the absolute bioavailability of triamcinolone acetonide following inhalation ad ministration. J Clin Pharmacol 39:695-702
20. Mackie AE, McDowall JE, Ventresca P, Bye A, Falcoz C, Daley-Yates PT 2000 Systemic exposure to fluticasone propionate administered vie metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant. Clin Pharmacokinet 39(Suppl 1):17-22.
21. Wilson AM, Lipworth BJ 1999 24 Hour and fractionated profiles of adreno cortical activity in asthmatic patients receiving inhaled and intranasal corti costeroids. Thorax 54:20-26
22. Wilson AM, Dempsey OJ, Coutie WJR, Sims EJ, Lipworth BJ 1999 Impor tance of drug-device interaction in determining systemic effects of inhaled corticosteroids. Lancet 353:2128
23. Dempsey OJ, Wilson AM, Coutie WJR, Lipworth BJ 1999 Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler. Chest 116:935-940